Unit survey, elderly care - Current routine is within home care for how drug reviews should be carried out in collaboration with different actors, where the individual's participation is documented in the medical records, elderly care, proportion (%)

For unit level, the value is given as "Yes, for both" = 2, "Yes, for simple" & "Yes, for deepened" = 1 and "No" = 0 while at municipality level it is only given as a proportion (%) of units where the answer is "Yes, for both". Number of units that have achieved the indicator divided by all units that have answered the survey question. Based on the questions: "Have you, on 1 March, written and at management level decided on routines for how simple and in-depth drug reviews", "Does the routine describe how collaboration at drug reviews should take place together with the individual, the doctor, the nurse and the home care staff at the unit? should be carried out in collaboration with the region?" and "Have you at any time during the last year (12 months) followed up the routine?". A simple drug review shall be offered to people 75 years of age and older with at least five drugs in accordance with the National Board of Health and Welfare's regulations and general advice HSLF-FS 2017:37. An in-depth drug review shall be offered to people who, after a simple drug review, have persistent drug-related problems or where there are suspicions of the presence of such problems.在单元层面，取值规则如下：“两项均符合（Yes, for both）”记为2，“仅符合简易版（Yes, for simple）”与“仅符合深化版（Yes, for deepened）”记为1，“不符合（No）”记为0；而在市镇层面，仅以回答“两项均符合”的单元占比（%）进行展示，该占比为已达成该指标的单元数除以所有作答该调研问题的单元总数。本次调研包含以下三项问题：“您是否已于3月1日制定并经管理层审批通过简易与深入药物审查（drug review）的相关流程？”“该流程是否明确了在单元层面需与服务对象、医师、护士及居家照护人员协作开展药物审查的相关要求？是否应与区域协同推进此项工作？”以及“您是否在过去一年（12个月）内对该流程进行过跟进？”根据瑞典国家卫生与福利委员会（National Board of Health and Welfare）的规章及通用指南HSLF-FS 2017:37，简易药物审查需面向75岁及以上且同时服用至少5种药物的人群提供；深入药物审查则需面向经简易药物审查后仍存在持续药物相关问题，或疑似存在此类问题的人群提供。